Comparative Study of Efficacy of Topical Minoxidil 5% and Combination of Topical Minoxidil 5%, Topical Azelaic Acid 1.5% and Topical Tretinoin 0.01% on the Basis of Dermoscopic Analysis in Androgenetic Alopecia


Anil S. Gugle
Vikrant M. Jadhav
Rahul Kote
Milind Devidas Deshmukh
Aditi Vijay Dalvi


Background: Androgenetic alopecia (AGA) more commonly known as male pattern baldness affects up to 50% of men worldwide. Tretinoin prolongs anagen phase and increases percutaneous absorption of minoxidil three fold. Azelaic acid is an inhibitor of 5 alpha reductase and could be an effective agent in the treatment of androgen related pathology of human skin. Aims and Objective: 1) To study the efficacy of topical minoxidil 5% in treatment of androgenetic alopecia. 2) To study the efficacy of combination of topical minoxidil 5%, topical azelaic acid 1.5% and topical tretinoin 0.01% in treatment of androgenetic alopecia. 3) To compare the efficacy of foresaid topical preparation in treatment of androgenetic alopecia Setting: Outpatient department of Dermatology, Venerology Leprology of a tertiary health care centre with an attached medical college. Material and methods: Topical minoxidil 5 % lotion was used in 23 (50%) patients of the present study. Combination of topical minoxidil 5%, azelaic acid 1.5 % and tretinoin 0.01 % lotion was used in 23 (50 %) patients of the present study. Statistical analysis used: Epi info version 7. Results: There was statistically significant increase in hair number and thickness after treatment in both the groups. The comparison of the increase of hair number and thickness was statistically insignificant. Conclusions: Topical Minoxidil 5% is equally effective to combination of topical Minoxidil 5%, azelaic acid 1.5% and tretinoin 0.01% in treatment of androgenetic alopecia.


How to Cite
Gugle, A. S., Jadhav, V. M., Kote, R., Deshmukh, M. D., & Dalvi, A. V. (2015). Comparative Study of Efficacy of Topical Minoxidil 5% and Combination of Topical Minoxidil 5%, Topical Azelaic Acid 1.5% and Topical Tretinoin 0.01% on the Basis of Dermoscopic Analysis in Androgenetic Alopecia. MVP Journal of Medical Sciences, 90–99. Retrieved from


  1. Springer K, Brown M, Stulberg DL. Common hair loss disorders. Am Fam Physician. 2003 Jul 1; 68(1):93–102.
  2. Thomas J. Androgenetic alopecia. Current status. Indian J Dermatol. 2005; 50:179–90.
  3. Cash TF. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol. 1992 Jun; 26(6):926–31.
  4. Mezick JA, Gendimenico GJ, Liebel FT, Stenn KS. Androgen-induced delay of hair growth in the golden Syrian hamster. Br J Dermatol. 1999 Jun; 140(6):1100–4.
  5. Hanneken S, Ritzmann S, Nöthen MM, Kruse R. Androgenetic alopecia: Current aspects of a common phenotype. Hautarzt. 2003; 54:703–12.
  6. Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis andpotential for therapy. Expert Rev Mol Med. 2002 Nov 19; 4(22):1–11.
  7. Dhurat R, Saraogi P. Hair evaluation methods: merits and demerits. Int J Trichology. 2009 Jul; 1(2):108–19.
  8. Ross EK, Vincenzi C, Tosti A. Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol. 2006 Nov; 55(5):799–806.
  9. Olszewska M, Rudnicka L, Rakowska A, Kowalska-Oledzka E, Slowinska M.Trichoscopy. Arch Dermatol. 2008 Aug; 144(8):1007.
  10. Tosti A, Whiting D, Iorizzo M, Pazzaglia M, Misciali C, Vincenzi C, Micali G. The role of scalp dermoscopy in the diagnosis of alopecia areata incognita. J Am Acad Dermatol. 2008 Jul; 59(1):64–7.
  11. Toncić RJ, Lipozencić J, Pastar Z. Videodermoscopy in the evaluation of hair and scalp disorders. Acta Dermatovenerol Croat. 2007;15(2):116–8.
  12. Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil,placebo, or no treatment. J Am Acad Dermatol. 1999 Nov; 41(5 Pt 1):717– 21.
  13. Sinclair RD, Dawber RP. Androgenetic alopecia in men and women. Clin Dermatol. 2001 Mar-Apr; 19(2):167–78.
  14. Price VH. Treatment of hair loss. N Engl J Med. 1999 Sep 23; 341(13):964–73.
  15. Tosti A, Camacho-Martinez F, Dawber R. Management of androgenetic alopecia. J Eur Acad Dermatol Venereol. 1999 May; 12(3):205–14.
  16. Ross EK, Shapiro J. Management of hair loss. Dermatol Clin. 2005Apr; 23(2):227–43.
  17. Bergfeld WF. Retinoids and hair growth. J Am Acad Dermatol. 1998 Aug; 39(2 Pt 3):S86–9.
  18. Ferry JJ, Forbes KK, VanderLugt JT, Szpunar GJ. Influence of tretinoin on the 18. percutaneous absorption of minoxidil from an aqueous topical solution. Clin Pharmacol Ther. 1990 Apr; 47(4):439–46.
  19. Stamatiadis D, Bulteau-Portois MC, Mowszowicz I. Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid. Br J Dermatol.1988 Nov; 119(5):627–32.
  20. Goh CL. A retrospective study on the characteristics of androgenetic alopecia among Asian races in the National Skin Centre, a tertiary dermatological referralcentre in Singapore. Ann Acad Med Singapore. 2002 Nov; 31(6):751–5.
  21. Shin HS, Won CH, Lee SH, Kwon OS, Kim KH, Eun HC. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial. Am J Clin Dermatol. 2007; 8(5):285–90.
  22. Krupa Shankar D, Chakravarthi M, Shilpakar R. Male androgenetic alopecia: population-based study in 1,005 subjects. Int J Trichology. 2009 Jul; 1(2):131–3.
  23. Sehgal VN, Kak R, Aggarwal A, Srivastava G, Rajput P. Male pattern androgenetic alopecia in an Indian context: a perspective study. J Eur Acad Dermatol Venereol. 2007 Apr; 21(4):473–9.
  24. Smith MA, Wells RS. Male-type alopecia, alopecia areata, and normal hair in Women; family histories. Arch Dermatol. 1964 Jan; 89:95–8.
  25. Paik JH, Yoon JB, Sim WY, Kim BS, Kim NI. The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol. 2001 Jul; 145(1):95–9.
  26. Wang TL, Zhou C, Shen YW, Wang XY, Ding XL, Tian S, Liu Y, Peng GH, Xue SQ, Zhou JE, Wang RL, Meng XM, Pei GD, Bai YH, Liu Q, Li H, Zhang JZ. Prevalence of androgenetic alopecia in China: a community-based study in six cities. Br J Dermatol. 2010 Apr; 162(4):843–7.
  27. Pazoki-Toroudi H, Babakoohi S, Nilforoushzadeh MA, Nassiri-Kashani M, Shizarpour M, Ajami M, Habibey R, Sadr B, Rashighi-Firoozabadi M, Firooz A. Therapeutic effects of minoxidil high extra combination therapy in patients with androgenetic alopecia. Skinmed. 2012 Sep-Oct; 10(5):276–82.
  28. Bazzano GS, Terezakis N, Galen W. Topical tretinoin for hair growth promotion. J Am Acad Dermatol. 1986 Oct; 15(4 Pt 2):880–3, 890–3.
  29. Buhl AE, Waldon DJ, Baker CA, Johnson GA. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol. 1990 Nov; 95(5):553–7.

Most read articles by the same author(s)